Immunai joins 10x Genomics program to boost drug development
Together, the two companies say can give drugmakers a better view at the cellular level of how a patient’s immune system is responding to a cerain therapy.
10X Genomics nets $55M for next-gen sequencing products
10X Genomics' product suite uses whole genome sequencing, single gene expression analysis and careful exome analysis to unveil new structural variants and haplotypes - thus painting a broader picture of human health.
Health Executives on Digital Transformation in Healthcare
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.
Brace yourself for more agenda-setting conversations about personalized medicine
The ripple-effect of last week’s 23andMe news is just the beginning. A new study and an important genomics conference will only further highlight the opportunities coming in personalized medicine. New analysis from Frost & Sullivan, Future of Personalized Genomics, shows that genetic tests provided by companies straight to consumers via the e-commerce platform are more affordable […]